Nikolas Plevris

1.3k total citations
53 papers, 699 citations indexed

About

Nikolas Plevris is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Nikolas Plevris has authored 53 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 34 papers in Epidemiology and 16 papers in Immunology. Recurrent topics in Nikolas Plevris's work include Inflammatory Bowel Disease (40 papers), Microscopic Colitis (29 papers) and Biosimilars and Bioanalytical Methods (12 papers). Nikolas Plevris is often cited by papers focused on Inflammatory Bowel Disease (40 papers), Microscopic Colitis (29 papers) and Biosimilars and Bioanalytical Methods (12 papers). Nikolas Plevris collaborates with scholars based in United Kingdom, Netherlands and Spain. Nikolas Plevris's co-authors include Charlie W. Lees, Gareth‐Rhys Jones, Ian Arnott, Philip Jenkinson, Mathew Lyons, Colin Noble, James Fulforth, Alan G. Shand, Spyros I. Siakavellas and Shahida Din and has published in prestigious journals such as Gastroenterology, Gut and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Nikolas Plevris

41 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikolas Plevris United Kingdom 14 528 423 234 177 57 53 699
Virginia Solitano Italy 16 540 1.0× 344 0.8× 202 0.9× 166 0.9× 36 0.6× 84 774
Luís Correia Portugal 14 509 1.0× 417 1.0× 220 0.9× 135 0.8× 24 0.4× 52 705
Paula Ministro Portugal 15 420 0.8× 333 0.8× 224 1.0× 93 0.5× 28 0.5× 58 647
Richard A. Lirio United States 11 656 1.2× 513 1.2× 247 1.1× 182 1.0× 26 0.5× 30 847
B Huang Canada 9 893 1.7× 770 1.8× 269 1.1× 199 1.1× 44 0.8× 32 1.0k
Philip Jenkinson United Kingdom 10 308 0.6× 247 0.6× 137 0.6× 107 0.6× 37 0.6× 22 421
Rocío Sedaño Canada 13 412 0.8× 314 0.7× 157 0.7× 129 0.7× 21 0.4× 47 577
Wendy Kampman United States 4 771 1.5× 650 1.5× 207 0.9× 201 1.1× 42 0.7× 8 903
Juan Ricardo Márquez Colombia 8 790 1.5× 628 1.5× 274 1.2× 199 1.1× 26 0.5× 24 952
Mathurin Fumery France 15 1.1k 2.1× 890 2.1× 458 2.0× 157 0.9× 46 0.8× 28 1.3k

Countries citing papers authored by Nikolas Plevris

Since Specialization
Citations

This map shows the geographic impact of Nikolas Plevris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolas Plevris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolas Plevris more than expected).

Fields of papers citing papers by Nikolas Plevris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolas Plevris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolas Plevris. The network helps show where Nikolas Plevris may publish in the future.

Co-authorship network of co-authors of Nikolas Plevris

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolas Plevris. A scholar is included among the top collaborators of Nikolas Plevris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolas Plevris. Nikolas Plevris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gros, Beatriz, Nikolas Plevris, Mathew Lyons, et al.. (2025). Twenty‐Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland. Alimentary Pharmacology & Therapeutics. 62(7). 699–709.
2.
Gros, Beatriz, et al.. (2025). OP07 Psychosocial factors are associated with risk of flare in IBD; results from the PREdiCCt study. Journal of Crohn s and Colitis. 19(Supplement_1). i13–i15. 1 indexed citations
3.
Plevris, Nikolas, et al.. (2025). P0626 One year outcomes of upadacitinib in Crohn’s disease in a large real-world cohort. Journal of Crohn s and Colitis. 19(Supplement_1). i1235–i1236.
4.
Sazonovs, Aleksejs, Nikolas Plevris, Filip Ottosson, et al.. (2025). OP19 Pre- and Post-diagnostic Metabolomic Biomarker Profiling of Over 700,000 Individuals in Three National Biobanks Enables Prediction of Inflammatory Bowel Disease Onset and Complications. Journal of Crohn s and Colitis. 19(Supplement_1). i38–i40.
5.
Plevris, Nikolas, Beatriz Gros, James Goodhand, et al.. (2024). P823 Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study. Journal of Crohn s and Colitis. 18(Supplement_1). i1523–i1525.
6.
Gros, Beatriz, Lauranne Derikx, Mathew Lyons, et al.. (2024). Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. Therapeutic Advances in Gastroenterology. 17. 1118441348–1118441348. 6 indexed citations
7.
Gros, Beatriz, J D Kennedy, Colin Noble, et al.. (2024). Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison. Journal of Crohn s and Colitis. 19(7).
8.
Plevris, Nikolas, Beatriz Gros, James Goodhand, et al.. (2024). Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study. Frontline Gastroenterology. 15(4). 297–304. 10 indexed citations
9.
Jones, Gareth‐Rhys, Nikolas Plevris, Hayley Hutchings, et al.. (2023). Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset. Journal of Crohn s and Colitis. 18(2). 286–290. 1 indexed citations
10.
Plevris, Nikolas, Lauranne Derikx, Beatriz Gros, et al.. (2023). Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease. Clinical Gastroenterology and Hepatology. 21(11). 2918–2927.e6. 3 indexed citations
11.
Gros, Beatriz, Nikolas Plevris, Mathew Lyons, et al.. (2023). Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort. United European Gastroenterology Journal. 11(2). 179–188. 12 indexed citations
12.
Lees, Charlie W., Beatriz Gros, Nikolas Plevris, et al.. (2023). 477c HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY. Gastroenterology. 164(6). S–1571. 1 indexed citations
13.
Plevris, Nikolas, et al.. (2022). P489 Temporal trends of colectomy for ulcerative colitis in the multi-drug era; a population based cohort study. Journal of Crohn s and Colitis. 16(Supplement_1). i455–i456. 1 indexed citations
14.
Plevris, Nikolas, et al.. (2021). Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology. 14. 1088246980–1088246980. 20 indexed citations
15.
Siakavellas, Spyros I., Mathew Lyons, Nikolas Plevris, et al.. (2021). P155 88000 faecal calprotectin measurements over 15 years: insights gained from the edinburgh faecal calprotectin register. A123–A124. 3 indexed citations
16.
Cohen, Nathaniel A., Nikolas Plevris, Uri Kopylov, et al.. (2020). Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study. United European Gastroenterology Journal. 8(9). 1076–1085. 32 indexed citations
17.
Kennedy, Nicholas A., et al.. (2019). Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease. Clinical Gastroenterology and Hepatology. 17(11). 2269–2276.e4. 41 indexed citations
18.
Jones, Gareth‐Rhys, Mathew Lyons, Nikolas Plevris, et al.. (2019). OWE-04 A capture-recapture study of all-age IBD point prevalence in scotland. A63–A64.
19.
Plevris, Nikolas, Rohit Sinha, Alastair Hay, et al.. (2018). Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease. Alimentary Pharmacology & Therapeutics. 48(4). 423–430. 12 indexed citations
20.
Plevris, Nikolas, Philip Jenkinson, Mathew Lyons, et al.. (2018). DOP072 Achieving biochemical remission with adalimumab therapy using therapeutic drug monitoring: Results of a large prospective Crohn’s disease cohort. Journal of Crohn s and Colitis. 12(supplement_1). S079–S080.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Solitano Breakdown of academic impact, for papers by Luís Correia Breakdown of academic impact, for papers by Paula Ministro Breakdown of academic impact, for papers by Richard A. Lirio Breakdown of academic impact, for papers by B Huang Breakdown of academic impact, for papers by Philip Jenkinson Breakdown of academic impact, for papers by Rocío Sedaño Breakdown of academic impact, for papers by Wendy Kampman Breakdown of academic impact, for papers by Juan Ricardo Márquez Breakdown of academic impact, for papers by Mathurin Fumery
Rankless by CCL
2026